PedAM
Pediatric Disease Annotations & Medicines
| Disease | cardiogenic shock |
| Phenotype | |myocardial infarct |
| Sentences | 155 |
| PubMedID- 19789449 | Acute kidney injury in st-segment elevation acute myocardial infarction complicated by cardiogenic shock at admission. |
| PubMedID- 20648428 | Blood glucose level on admission determines in-hospital and long-term mortality in patients with st-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention. |
| PubMedID- 21735410 | Selection criteria: randomised controlled trials on patients with myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 25912694 | Background: the effect of abciximab on survival in patients with st-elevation myocardial infarction (stemi) complicated by cardiogenic shock (cs) undergoing primary percutaneous coronary intervention (pci) is not clear. |
| PubMedID- 23616484 | Objectives: the twin aims of this study were to identify the independent predictors of 30-day mortality and to analyse the outcomes of patients with cardiogenic shock (cs) associated with acute myocardial infarction (ami) and necessitating extracorporeal life support (ecls). |
| PubMedID- 22913597 | Acute left main occlusion is a rare but devastating presentation of myocardial infarction, invariably with cardiogenic shock. |
| PubMedID- 24725532 | Clinical impact of intra-aortic balloon pump during extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 24492986 | We report the results of four patients with st elevation myocardial infarction, complicated by cardiogenic shock unsuitable for intra-aortic balloon pump counterpulsation treated with early levosimendan infusion during primary percutaneous coronary intervention. |
| PubMedID- 26453047 | cardiogenic shock resulted from acute myocardial infarction in 17 patients (43 %), dilated cardiomyopathy in 12 (30 %) and postcardiotomy cardiac failure in 7 (18 %). |
| PubMedID- 24170231 | Background: recent evidence questions the role of intra-aortic balloon counterpulsation (iabp) in the treatment of acute myocardial infarction (ami) complicated by cardiogenic shock (cs). |
| PubMedID- 22299378 | Early revascularization is the cornerstone treatment of acute myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 22847042 | Efficacy and timing of intra-aortic counterpulsation in patients with st-elevation myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 21526919 | Background: the outcome of acute myocardial infarction (ami) complicated with cardiogenic shock is poor. |
| PubMedID- 20346312 | Despite early revascularization, mortality remains high in patients with st-segment elevation myocardial infarction (stemi) complicated by cardiogenic shock. |
| PubMedID- 22322287 | Efficacy of veno-arterial extracorporeal membrane oxygenation in acute myocardial infarction with cardiogenic shock. |
| PubMedID- 22266974 | Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized iabp shock trial. |
| PubMedID- 23453102 | Background: although radial approach is increasingly used in percutaneous coronary interventions (pcis) including in acute myocardial infarction (mi), patients with cardiogenic shock have been excluded from comparisons with femoral approach. |
| PubMedID- 22019211 | Left main coronary artery transradial rescue percutaneous coronary intervention for acute myocardial infarction complicated by cardiogenic shock with impella ventricular mechanical support. |
| PubMedID- 23441474 | The terminal cardiogenic shock was associated with myocardial infarction. |
| PubMedID- 25536812 | Conclusion: the prompt diagnosis, especially in such relatively atypical clinical presentation, reperfusion therapy with primary percutaneous coronary intervention in acute myocardial infarction complicated by cardiogenic shock, contribute to the improvement in the survival rate and patient's quality of life. |
| PubMedID- 23508129 | Background and objectives: the benefit of early statin treatment following acute myocardial infarction (mi) complicated with cardiogenic shock (cs) has not been well studied. |
| PubMedID- 24848410 | Recent findings: recently published randomized controlled trials (rcts) and meta-analyses have demonstrated acceptable safety for iabp but have raised doubt over efficacy in acute myocardial infarction (mi) both with and without cardiogenic shock. |
| PubMedID- 24342343 | Support or not to support the left ventricle in patients with acute myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 24494769 | This article presents a case study involving a man with acute myocardial infarction complicated by cardiogenic shock and pulmonary oedema. |
| PubMedID- 24610504 | Background: the influence of age on clinical results of primary percutaneous coronary intervention (pci) in patients with st-elevation myocardial infarctions (stemi) complicated by cardiogenic shock (cs) is poorly investigated. |
| PubMedID- 24228641 | Objectives: to assess the relation between initial ecg findings, presence of risk factors, coronary angiography findings, and clinical outcomes in patients with acute myocardial infarction complicated by cardiogenic shock (cs). |
| PubMedID- 23264238 | The influence of diabetes on in-hospital and long-term mortality in patients with myocardial infarction complicated by cardiogenic shock: results from the pl-acs registry. |
| PubMedID- 25489303 | Impact of intra-aortic balloon pump on long-term mortality of unselected patients with st-segment elevation myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 23831043 | [acute myocardial infarction complicated by cardiogenic shock: what changed over a 10-year time span. |
| PubMedID- 21285933 | Early revascularization is the cornerstone treatment of acute myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 23468450 | A 34-year-old male patient was referred for primary percutaneous coronary intervention for st-segment elevation myocardial infarction with cardiogenic shock and was found to have embolic left coronary artery occlusion and subsegmental pulmonary artery emboli as a consequence of venous thrombosis to trauma to the thigh in the presence of a patent foramen ovale. |
| PubMedID- 24954319 | Clinical outcomes of patients with acute myocardial infarction complicated by severe refractory cardiogenic shock assisted with percutaneous cardiopulmonary support. |
| PubMedID- 22709745 | Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the intraaortic balloon pump in cardiogenic shock ii (iabp-shock ii) trial. |
| PubMedID- 25170414 | We report the first case of spontaneous multivessel spasm in a male patient with bronchial asthma of arab ethnicity resulting in acute myocardial infarction complicated by cardiogenic shock, recurrent ventricular arrhythmias, and transient complete heart block. |
| PubMedID- 22121422 | We diagnosed acute anterior myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 24903195 | Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the iabp-shock ii-trial. |
| PubMedID- 25965624 | Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: a biomarker substudy of the iabp-shock ii-trial. |
| PubMedID- 24133507 | Though there were three (8.8%) in-hospital deaths in our patients, none were procedure-related and all were caused by underlying extensive myocardial infarction with cardiogenic shock. |
| PubMedID- 22126854 | The presence of st-elevation in lead avr predicts significant left main coronary artery stenosis in cardiogenic shock resulting from myocardial infarction: the manitoba cardiogenic shock registry. |
| PubMedID- 24364017 | [71] evaluated right ventricular function in 25 consecutive acute myocardial infarction patients with cardiogenic shock not responding sufficiently to conventional treatment. |
| PubMedID- 22212516 | Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 20686421 | Objective: to assess the predictive value of three biomarkers for mortality in st-segment elevation myocardial infarction (stemi) with cardiogenic shock. |
| PubMedID- 25136881 | Immediate multivessel percutaneous coronary intervention versus culprit lesion intervention in patients with acute myocardial infarction complicated by cardiogenic shock: results of the alkk-pci registry. |
| PubMedID- 24791717 | Transradial versus transfemoral coronary intervention for acute myocardial infarction complicated by cardiogenic shock: is transradial coronary intervention suitable for emergency pci in high-risk acute myocardial infarction. |
| PubMedID- 24385385 | Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome. |
| PubMedID- 20089520 | Right ventricular dysfunction is an independent predictor for mortality in st-elevation myocardial infarction patients presenting with cardiogenic shock on admission. |
| PubMedID- 21764661 | Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the euro heart survey on pci. |
| PubMedID- 23569569 | We present a case report where cocaine, used as a topical anesthetic agent in nasal surgery, induced a st-segment elevation myocardial infarction (stemi) with cardiogenic shock and ventricular arrhythmias secondary to diffuse coronary spasm. |
| PubMedID- 21944148 | It may be especially useful in patients with acute myocardial infarction complicated by cardiogenic shock who achieve intermacs profile 3 with initial treatment. |
| PubMedID- 24077607 | Recent findings: there have been decades of nonrandomized and observational data available, but only in the last 3 years has there been availability of randomized evidence for iabp use in acute myocardial infarction (ami) with cardiogenic shock, st elevation acute coronary syndromes (ste-acs) without shock and high-risk percutaneous coronary intervention (pci) cohorts. |